TROX
Tronox Holdings plc
Chemicals
Market Cap$1.34B
5Y Perf.+26.7%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
TROX vs CC vs KRO vs HUN vs EMN
Revenue, margins, valuation, and 5-year total return — side by side.
CC
The Chemours Company
Chemicals - Specialty
Market Cap$3.36B
5Y Perf.+70.9%
KRO
Kronos Worldwide, Inc.
Chemicals - Specialty
Market Cap$811M
5Y Perf.-27.8%
HUN
Huntsman Corporation
Chemicals
Market Cap$2.56B
5Y Perf.-18.8%
EMN
Eastman Chemical Company
Chemicals - Specialty
Market Cap$8.43B
5Y Perf.+8.2%
TROX vs CC vs KRO vs HUN vs EMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | TROX | CC | KRO | HUN | EMN |
|---|---|---|---|---|---|
| Industry | Chemicals | Chemicals - Specialty | Chemicals - Specialty | Chemicals | Chemicals - Specialty |
| Market Cap | $1.34B | $3.36B | $811M | $2.56B | $8.43B |
| Revenue (TTM) | $2.92B | $5.82B | $1.88B | $5.69B | $8.64B |
| Net Income (TTM) | $-359M | $-411M | $-134M | $-324M | $399M |
| Gross Margin | 5.8% | 15.1% | 10.1% | 12.9% | 19.8% |
| Operating Margin | -4.8% | -0.8% | -3.1% | -1.0% | 9.4% |
| Forward P/E | — | 15.5x | — | — | 12.5x |
| Total Debt | $3.59B | $4.58B | $577M | $2.73B | $5.08B |
| Cash & Equiv. | $211M | $672M | $37M | $429M | $566M |
TROX vs CC vs KRO vs HUN vs EMN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
TROX
CC
KRO
HUN
EMN
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Tronox Holdings plc (TROX) | 100 | 126.7 | +26.7% |
| The Chemours Company (CC) | 100 | 170.9 | +70.9% |
| Kronos Worldwide, I… (KRO) | 100 | 72.2 | -27.8% |
| Huntsman Corporation (HUN) | 100 | 81.2 | -18.8% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TROX vs CC vs KRO vs HUN vs EMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: EMN leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. The Chemours Company is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. HUN also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
TROX
Tronox Holdings plc
The Income Angle
TROX lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: basic materials exposure
CC
The Chemours Company
The Growth Play
CC is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 0.4%, EPS growth -5.5%, 3Y rev CAGR -5.3%
- 219.7% 10Y total return vs KRO's 129.0%
- 0.4% revenue growth vs EMN's -6.7%
- +108.8% vs KRO's -1.2%
Best for: growth exposure and long-term compounding
KRO
Kronos Worldwide, Inc.
The Defensive Pick
KRO is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.57, Low D/E 76.9%, current ratio 2.70x
Best for: sleep-well-at-night
HUN
Huntsman Corporation
The Income Pick
HUN ranks third and is worth considering specifically for dividends.
- 5.7% yield, vs EMN's 4.5%
Best for: dividends
EMN
Eastman Chemical Company
The Income Pick
EMN carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 1.36, yield 4.5%
- Beta 1.36, yield 4.5%, current ratio 1.37x
- Better valuation composite
- 4.6% margin vs TROX's -12.3%
Best for: income & stability and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CC | 0.4% revenue growth vs EMN's -6.7% |
| Value | EMN | Better valuation composite |
| Quality / Margins | EMN | 4.6% margin vs TROX's -12.3% |
| Stability / Safety | EMN | Beta 1.36 vs TROX's 2.37, lower leverage |
| Dividends | HUN | 5.7% yield, vs EMN's 4.5% |
| Momentum (1Y) | CC | +108.8% vs KRO's -1.2% |
| Efficiency (ROA) | EMN | 2.6% ROA vs KRO's -9.4%, ROIC 6.7% vs -1.9% |
TROX vs CC vs KRO vs HUN vs EMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2014
FY 2025
FY 2025
TROX vs CC vs KRO vs HUN vs EMN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLEMNLAGGINGHUN
Who Leads Where
EMN leads in 3 of 6 categories
CC leads 1 • TROX leads 0 • KRO leads 0 • HUN leads 0 • 2 tied
Explore the data ↓HUNHuntsman Corporation
0leads
KROKronos Worldwide, Inc.
0leads
TROXTronox Holdings plc
0leads
CCThe Chemours Company
1leads
EMNEastman Chemical Comp…
3leads
6 Total Categories
CATEGORYLEADERvs CCvs TROXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
EMN4/6
Valuation MetricsMultiples, price ratios, and targets
EMN3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
EMN6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CC3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
EMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMN is the larger business by revenue, generating $8.6B annually — 4.6x KRO's $1.9B. EMN is the more profitable business, keeping 4.6% of every revenue dollar as net income compared to TROX's -12.3%. On growth, KRO holds the edge at +4.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | TROXTronox Holdings p… | CCThe Chemours Comp… | KROKronos Worldwide,… | HUNHuntsman Corporat… | EMNEastman Chemical … |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $5.8B | $1.9B | $5.7B | $8.6B |
| EBITDAEarnings before interest/tax | $166M | -$132M | -$9M | $160M | $1.2B |
| Net IncomeAfter-tax profit | -$359M | -$411M | -$134M | -$324M | $399M |
| Free Cash FlowCash after capex | -$139M | $198M | $35M | $135M | $498M |
| Gross MarginGross profit ÷ Revenue | +5.8% | +15.1% | +10.1% | +12.9% | +19.8% |
| Operating MarginEBIT ÷ Revenue | -4.8% | -0.8% | -3.1% | -1.0% | +9.4% |
| Net MarginNet income ÷ Revenue | -12.3% | -7.1% | -7.1% | -5.7% | +4.6% |
| FCF MarginFCF ÷ Revenue | -4.8% | +3.4% | +1.9% | +2.4% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.0% | +1.0% | +4.1% | +0.7% | -4.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +7.1% | -6.1% | -126.1% | -3.3% | -40.8% |
EMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
EMN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | TROXTronox Holdings p… | CCThe Chemours Comp… | KROKronos Worldwide,… | HUNHuntsman Corporat… | EMNEastman Chemical … |
|---|---|---|---|---|---|
| Market CapShares × price | $1.3B | $3.4B | $811M | $2.6B | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $4.7B | $7.3B | $1.4B | $4.9B | $12.9B |
| Trailing P/EPrice ÷ TTM EPS | -2.83x | -8.75x | -7.34x | -9.27x | 17.97x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 15.55x | — | — | 12.50x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 5.59x |
| EV / EBITDAEnterprise value multiple | 16.80x | 21.72x | 40.71x | 19.64x | 8.96x |
| Price / SalesMarket cap ÷ Revenue | 0.46x | 0.58x | 0.44x | 0.45x | 0.96x |
| Price / BookPrice ÷ Book value/share | 0.92x | 13.44x | 1.08x | 0.86x | 1.41x |
| Price / FCFMarket cap ÷ FCF | — | 65.93x | — | 22.11x | 19.87x |
EMN leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
EMN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-163 for CC. KRO carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), KRO scores 5/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | TROXTronox Holdings p… | CCThe Chemours Comp… | KROKronos Worldwide,… | HUNHuntsman Corporat… | EMNEastman Chemical … |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -30.4% | -163.4% | -17.0% | -8.1% | +6.7% |
| ROA (TTM)Return on assets | -7.7% | -5.5% | -9.4% | -4.6% | +2.6% |
| ROICReturn on invested capital | -0.3% | -0.1% | -1.9% | -0.6% | +6.7% |
| ROCEReturn on capital employed | -0.4% | -0.1% | -2.2% | -0.7% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 5 | 2 | 5 |
| Debt / EquityFinancial leverage | 2.48x | 18.27x | 0.77x | 0.92x | 0.84x |
| Net DebtTotal debt minus cash | $3.4B | $3.9B | $540M | $2.3B | $4.5B |
| Cash & Equiv.Liquid assets | $211M | $672M | $37M | $429M | $566M |
| Total DebtShort + long-term debt | $3.6B | $4.6B | $577M | $2.7B | $5.1B |
| Interest CoverageEBIT ÷ Interest expense | -1.16x | 1.15x | -2.32x | -1.08x | 2.22x |
EMN leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CC five years ago would be worth $7,726 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, CC leads with a +108.8% total return vs KRO's -1.2%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs HUN's -12.6% — a key indicator of consistent wealth creation.
| Metric | TROXTronox Holdings p… | CCThe Chemours Comp… | KROKronos Worldwide,… | HUNHuntsman Corporat… | EMNEastman Chemical … |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +98.1% | +83.6% | +58.5% | +45.5% | +15.8% |
| 1-Year ReturnPast 12 months | +76.9% | +108.8% | -1.2% | +37.5% | +2.3% |
| 3-Year ReturnCumulative with dividends | -23.6% | -15.7% | -0.7% | -33.3% | +3.4% |
| 5-Year ReturnCumulative with dividends | -55.1% | -22.7% | -43.9% | -39.8% | -28.4% |
| 10-Year ReturnCumulative with dividends | +116.1% | +219.7% | +129.0% | +57.6% | +35.4% |
| CAGR (3Y)Annualised 3-year return | -8.6% | -5.5% | -0.2% | -12.6% | +1.1% |
CC leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — HUN and EMN each lead in 1 of 2 comparable metrics.
Risk & Volatility
EMN is the less volatile stock with a 1.36 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 92.7% from its 52-week high vs CC's 78.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | TROXTronox Holdings p… | CCThe Chemours Comp… | KROKronos Worldwide,… | HUNHuntsman Corporat… | EMNEastman Chemical … |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.37x | 1.92x | 1.57x | 1.73x | 1.36x |
| 52-Week HighHighest price in past year | $10.59 | $28.67 | $7.90 | $15.89 | $84.18 |
| 52-Week LowLowest price in past year | $2.86 | $9.13 | $4.08 | $7.30 | $56.11 |
| % of 52W HighCurrent price vs 52-week peak | +79.4% | +78.1% | +89.2% | +92.7% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 48.1 | 63.4 | 65.4 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 3.1M | 3.1M | 350K | 6.2M | 1.5M |
Evenly matched — HUN and EMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — HUN and EMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TROX as "Buy", CC as "Hold", KRO as "Hold", HUN as "Hold", EMN as "Buy". Consensus price targets imply 4.9% upside for EMN (target: $77) vs -29.1% for KRO (target: $5). For income investors, HUN offers the higher dividend yield at 5.74% vs CC's 2.31%.
| Metric | TROXTronox Holdings p… | CCThe Chemours Comp… | KROKronos Worldwide,… | HUNHuntsman Corporat… | EMNEastman Chemical … |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $7.25 | $22.14 | $5.00 | $12.00 | $77.29 |
| # AnalystsCovering analysts | 17 | 20 | 7 | 33 | 35 |
| Dividend YieldAnnual dividend ÷ price | +3.6% | +2.3% | +2.8% | +5.7% | +4.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.30 | $0.52 | $0.20 | $0.85 | $3.30 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.1% | +1.2% |
Evenly matched — HUN and EMN each lead in 1 of 2 comparable metrics.
Key Takeaway
EMN leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CC leads in 1 (Total Returns). 2 tied.
Best OverallEastman Chemical Company (EMN)Leads 3 of 6 categories
Loading custom metrics...
TROX vs CC vs KRO vs HUN vs EMN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TROX or CC or KRO or HUN or EMN a better buy right now?
For growth investors, The Chemours Company (CC) is the stronger pick with 0.
4% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Tronox Holdings plc (TROX) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TROX or CC or KRO or HUN or EMN?
On forward P/E, Eastman Chemical Company is actually cheaper at 12.
5x.
03Which is the better long-term investment — TROX or CC or KRO or HUN or EMN?
Over the past 5 years, The Chemours Company (CC) delivered a total return of -22.
7%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: CC returned +219. 7% versus EMN's +35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TROX or CC or KRO or HUN or EMN?
By beta (market sensitivity over 5 years), Eastman Chemical Company (EMN) is the lower-risk stock at 1.
36β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 75% more volatile than EMN relative to the S&P 500. On balance sheet safety, Kronos Worldwide, Inc. (KRO) carries a lower debt/equity ratio of 77% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
05Which is growing faster — TROX or CC or KRO or HUN or EMN?
By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.
4% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Huntsman Corporation grew EPS -44. 5% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TROX or CC or KRO or HUN or EMN?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 7% for KRO. At the gross margin level — before operating expenses — EMN leads at 21. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TROX or CC or KRO or HUN or EMN more undervalued right now?
On forward earnings alone, Eastman Chemical Company (EMN) trades at 12.
5x forward P/E versus 15. 5x for The Chemours Company — 3. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMN: 4. 9% to $77. 29.
08Which pays a better dividend — TROX or CC or KRO or HUN or EMN?
All stocks in this comparison pay dividends.
Huntsman Corporation (HUN) offers the highest yield at 5. 7%, versus 2. 3% for The Chemours Company (CC).
09Is TROX or CC or KRO or HUN or EMN better for a retirement portfolio?
For long-horizon retirement investors, Eastman Chemical Company (EMN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.
5% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EMN: +35. 4%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TROX and CC and KRO and HUN and EMN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TROX is a small-cap income-oriented stock; CC is a small-cap quality compounder stock; KRO is a small-cap quality compounder stock; HUN is a small-cap income-oriented stock; EMN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(TROX: 3.0% · CC: 1.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.